Clinical Trial Update: Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy and safety of sequential hormone therapy followed by Tetuzumab in patients with moderate-to-severe thyroid-a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid-associated Ophthalmopathy

Drugs mentioned

• Tetuzumab (tetuzumab)
• glucocorticoids (glucocorticoids)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Thyroid Associated Ophthalmopathies | Phase 4 | Status: RECRUITING